Company news
Abbott Laboratories news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Abbott's Libre® Technology is First Continuous Glucose Monitor Associated with Reduced Hospitalizations for Heart Complications in People with Diabetes
May 15, 2025
Abbott and Real Madrid Kick Off Search to Empower Young Soccer Talent
May 7, 2025
MotoAmerica Becomes First Sports Organization to Use Abbott's Rapid Blood Test for Concussion Evaluation On-site at Races
May 1, 2025
Abbott Integrates Libre's Data with Epic's Electronic Health Record System, Providing Healthcare Professionals Seamless Glucose Monitoring Information
April 29, 2025
Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
April 27, 2025
New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib
April 26, 2025
Calls
The 5 newest of 32 calls. Every call is listed under its year.
- Abbott Laboratories (NYSE:ABT) Q3 2026 Earnings Call
Oct 21, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q2 2026 Earnings Call
Jul 16, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call
Apr 16, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call
Jan 22, 2026
Transcript - Abbott Laboratories (NYSE:ABT) Q3 2025 Earnings Call
Oct 15, 2025
Transcript
Decks
The 5 newest of 18 decks. Every deck is listed under its year.
- Merger or Acquisition (November 2025)
Merger or acquisition · 13 slides · Nov 20, 2025
- Technical Presentation (October 2025)
Technical · 16 slides · Oct 26, 2025
- Investor Presentation (October 2024)
Investor deck · 41 slides · October 2024
- Conference Presentation (October 2024)
Conference · 24 slides · October 2024
- Technical Presentation (November 2023)
Technical · 8 slides · November 2023